This suggests distinct tumor biology in metabolic syndrome-driven hepatocarcinogenesis, characterized by profoundly immunosuppressive features including CD8+ T-cell exhaustion, altered gut microbiota, and fibrotic stroma (32, 33). The gene discussed is CD8A; the disease is metabolic syndrome.